drugset / Trial / NCT01714973

Study of ST266 Versus Saline in Treating Skin Irritation From Radiation

NCT01714973 ↗

Phase 1 Completed 20 enrolled Noveome Biotherapeutics
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to evaluate the safety and efficacy of ST266 in treating radiation burns of the skin in patients undergoing treatments for breast cancer and to compare ST266 treated burns with those treated with saline placebo controls.

Timeline

Start
2012-10
Primary completion
2015-07
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject ST266 Protein / enzyme biologic 4 ml Other

Indications